New pill tested for brain conditions in early safety trial
Disease control
Recruiting now
This is the first study in humans to test the safety and tolerability of a new oral drug called Leucettinib-21. It will involve healthy volunteers and a small group of people with Down syndrome or Alzheimer's disease. The main goal is to see how the body handles the drug and to c…
Phase: PHASE1 • Sponsor: Perha Pharmaceuticals • Aim: Disease control
Last updated Apr 15, 2026 16:14 UTC